NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品编号 09530449 持证商 MCM KLOSTERFRAU Vertr. GmbH 包装规格 100 St 剂型 Hartkapseln 需要医生开处方 nein Apothekenpflichtig nein 信息来源:https://www.besamex.de/produkt/hepar-sl-320-mg-hartkapseln-100-st-09530449.html
产品名称:BACLOFEN上市时间:02/22/2023NDA/ANDA/BLA:217324持证商:RUBICONNDC:72888-145-36,72888-146-36,72888-147-36说明书:批准信:
产品名称:SUCCINYLCHOLINE CHLORIDE上市时间:02/22/2023NDA/ANDA/BLA:216003持证商:BE PHARMSNDC:说明书:批准信:
产品名称:DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE上市时间:02/22/2023NDA/ANDA/BLA:215771持证商:GRANULESNDC:70010-111-01,70010-112-01,70010-113-01,70010-114-01,70010-115-01,70010-116-01,70010-117-01说明书:批准信:
产品名称:SUCCINYLCHOLINE CHLORIDE上市时间:02/22/2023NDA/ANDA/BLA:214879持证商:MICRO LABSNDC:42571-371-87说明书:批准信:
产品名称:LAMPIT上市时间:02/22/2023NDA/ANDA/BLA:213464持证商:BAYER HEALTHCARENDC:50419-750-01,50419-751-01说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213464s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/213464Orig1s000ltr.pdf
产品名称:PITAVASTATIN CALCIUM上市时间:02/22/2023NDA/ANDA/BLA:206047持证商:ZYDUS PHARMSNDC:说明书:批准信:
产品名称:NORGESTIMATE; ETHINYL ESTRADIOL上市时间:02/22/2023NDA/ANDA/BLA:200494持证商:GLENMARK GENERICSNDC:50090-2603-0,68788-7894-2,68462-565-29,71205-191-28说明书:批准信:
产品名称:NORGESTIMATE AND ETHINYL ESTRADIOL上市时间:02/22/2023NDA/ANDA/BLA:200494持证商:GLENMARK GENERICSNDC:50090-2603-0,68788-7894-2,68462-565-29,71205-191-28说明书:批准信:
产品名称:SORIATANE上市时间:02/22/2023NDA/ANDA/BLA:19821持证商:STIEFEL LABS INCNDC:说明书:批准信:
产品名称:HALOBETASOL PROPIONATE上市时间:02/21/2023NDA/ANDA/BLA:214285持证商:PERRIGO ISRAELNDC:说明书:批准信: